InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（4 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
4
T+90 胜率
0%
T+90 平均收益
-3.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Carroll Jill, 首席财务官. Director active across 2 companies, notably Arcellx, Inc.. Aggregated, 9 reports have been published. Breakdown: 1 buy · 4 sells. Total volume traded: €97.8m. History available since 8 February 2022. The latest transaction was disclosed on 1 May 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Carroll Jill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
277,778 股@ US$18.000.29% mcap100.0% 占其流量Common StockSEC:0001193125-26-201894:2
标准退出：2026年7月30日 (T+90)
1,419,298 股Common StockSEC:0001193125-26-201894:0
489,486 股Common StockSEC:0001193125-26-201894:1
1,479,148 股Common StockSEC:0001193125-26-188029:0
504,263 股@ US$70.5534.8% 占其流量Common StockSEC:0000950170-24-036013:0
504,263 股@ US$49.1324.3% 占其流量Common StockSEC:0001209191-23-058974:0
315,164 股@ US$41.5013.1% 占其流量Common StockSEC:0001209191-23-033867:0
631,932 股@ US$45.0027.8% 占其流量Common StockSEC:0001209191-23-029613:0
3,400,144 股0Common StockSEC:0001209191-22-008157:0
9 条申报中的 9 条
About Carroll Jill
Carroll Jill is Directeur Financier. She has 9 filings in total. Across the 9 sampled recent filings, the period runs from 2022-02-09 to 2026-05-01, with EUR 4262903 of buys and EUR 93574119 of sells, and the main filings concern Arcellx, Inc. and Avalyn Pharma Inc.
